Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Provided By GlobeNewswire
Last update: Sep 2, 2025
NORCROSS, Ga., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today announced that the company management will participate in the H.C. Wainwright 27th Annual Global Investment Conference, taking place September 8-10, 2025 in New York, NY.
Read more at globenewswire.com
